Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964–2003 followed up to the end of 2006

Figures & data

Figure 1. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for patients of kidney cancer by sex and country. Nordic cancer survival study 1964–2003.

Table I. Trends in survival for kidney cancer by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	946	21 (18–24)	520	22 (18–27)	38	30 (23–41)	623	32 (28–38)	2 492	27 (25–29)
1969–1973	1 250	22 (19–24)	635	31 (25–39)	51	30 (23–41)	709	29 (25–34)	2 772	29 (27–31)
1974–1978	1 260	24 (22–27)	801	31 (27–37)	51	42 (29–62)	877	37 (33–42)	2 561	33 (31–36)
1979–1983	1 200	29 (26–32)	996	32 (29–36)	64	48 (35–64)	1 005	36 (33–40)	2 631	39 (37–42)
1984–1988	1 225	32 (29–36)	1 398	40 (36–43)	65	47 (33–66)	1 137	40 (37–44)	2 720	40 (38–43)
1989–1993	1 249	37 (34–40)	1 610	50 (47–54)	97	42 (32–55)	1 262	46 (42–49)	2 654	46 (43–48)
1994–1998	1 330	39 (35–42)	1 839	54 (51–57)	113	55 (45–67)	1 302	47 (44–51)	2 419	51 (48–53)
1999–2003	1 475	40 (38–43)	1 838	57 (54–59)	110	60 (51–70)	1 457	51 (49–54)	2 326	52 (50–54)
Women
1964–1968	743	25 (21–28)	459	26 (22–30)	23	33 (23–47)	428	36 (31–41)	1 822	31 (29–34)
1969–1973	958	25 (22–28)	593	33 (29–37)	34	33 (23–47)	521	37 (33–42)	2 069	35 (32–37)
1974–1978	965	25 (22–28)	672	35 (32–39)	39	49 (36–66)	572	38 (34–43)	1 784	38 (36–41)
1979–1983	959	31 (28–34)	855	39 (36–43)	45	32 (21–50)	678	44 (40–48)	1 864	41 (39–44)
1984–1988	970	37 (34–40)	1 199	47 (44–51)	56	36 (25–50)	772	46 (43–50)	1 989	43 (40–45)
1989–1993	980	35 (32–38)	1 333	55 (52–58)	61	54 (40–71)	856	53 (50–57)	2 005	50 (47–52)
1994–1998	975	40 (36–43)	1 441	59 (56–62)	69	50 (38–65)	931	52 (48–56)	1 839	55 (52–58)
1999–2003	960	41 (38–43)	1 508	62 (60–64)	79	52 (43–63)	936	55 (52–58)	1 654	57 (55–59)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

Table II. Trends in 5-year age-specific relative survival in percent after kidney cancer by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	33	29	23	15	9	*	35	33	31	17	9	0
1969–1973	44	33	20	15	5	0	46	35	24	20	7	0
1974–1978	48	32	25	19	3	0	43	34	30	18	5	0
1979–1983	51	37	29	23	13	0	51	31	35	28	11	0
1984–1988	52	42	31	24	24	0	59	39	34	33	28	0
1989–1993	56	41	39	33	19	0	60	42	32	33	13	99
1994–1998	60	40	38	38	21	0	76	51	40	30	16	22
1999–2003	64	46	39	39	17	0	76	54	37	33	17	12
Finland
1964–1968	38	24	20	26	0	*	47	41	24	22	0	*
1969–1973	48	33	28	18	46	*	50	39	45	28	0	*
1974–1978	46	34	30	31	20	*	62	51	37	30	4	*
1979–1983	49	43	35	26	12	*	58	50	41	32	22	*
1984–1988	63	50	38	38	17	*	77	60	44	44	22	0
1989–1993	64	50	51	49	41	*	79	68	58	47	33	0
1994–1998	70	54	57	50	43	0	79	72	61	55	36	0
1999–2003	73	57	59	56	41	0	81	70	67	56	40	13
Iceland
1964–1968	34	68	36	18	*	*	67	67	20	28	*	*
1969–1973	34	68	36	18	*	*	67	67	20	28	*	*
1974–1978	47	71	31	43	25	*	78	78	61	33	*	*
1979–1983	31	40	82	40	22	*	47	47	43	25	*	*
1984–1988	42	42	59	45	37	*	54	54	38	34	*	*
1989–1993	55	61	46	27	33	*	64	64	44	53	52	*
1994–1998	80	54	74	39	33	*	60	60	58	50	18	*
1999–2003	74	60	67	49	54	*	64	64	51	61	12	*
Norway
1964–1968	49	36	24	29	37	*	57	59	33	25	18	*
1969–1973	46	43	32	20	13	*	55	56	37	28	17	*
1974–1978	62	43	33	26	40	*	59	41	42	33	20	*
1979–1983	60	44	34	31	22	*	68	48	49	39	17	0
1984–1988	66	52	37	35	21	0	71	53	53	39	20	52
1989–1993	65	56	52	35	29	0	83	56	54	49	34	0
1994–1998	61	54	51	39	36	0	71	61	60	43	28	0
1999–2003	66	58	58	43	35	0	79	64	62	47	31	21
Sweden
1964–1968	45	36	31	19	9	28	49	46	36	22	9	0
1969–1973	56	37	32	20	8	0	61	44	40	25	12	0
1974–1978	54	45	36	24	16	0	66	49	44	30	10	0
1979–1983	56	46	41	37	20	0	63	53	45	33	20	0
1984–1988	63	49	42	34	21	0	63	52	43	38	25	14
1989–1993	66	52	44	43	32	0	70	59	51	45	30	13
1994–1998	66	56	51	48	37	0	74	57	56	52	40	0
1999–2003	69	58	53	50	36	46	74	62	57	55	43	21

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [9].

Figure 2. Trends in age-standardised (ICSS) excess death rates per 100 person years for kidney cancer by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003.

Figure 3. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for patients of bladder cancer by sex and country. Nordic cancer survival study 1964–2003.

Table III. Trends in survival for bladder cancer by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	2 939	47 (45–50)	880	37 (33–41)	37	55 (43–70)	983	35 (31–39)	3 490	52 (50–55)
1969–1973	3 924	51 (49–53)	1 205	46 (42–50)	61	55 (43–70)	1 882	56 (53–59)	4 557	58 (56–60)
1974–1978	4 834	56 (54–58)	1 641	55 (52–59)	82	69 (57–84)	2 644	63 (60–65)	5 414	65 (64–67)
1979–1983	5 482	61 (60–63)	1 933	64 (61–67)	142	72 (63–82)	2 627	60 (57–62)	5 968	68 (67–70)
1984–1988	6 037	63 (62–65)	2 334	68 (65–70)	150	72 (63–82)	2 816	64 (62–67)	7 030	71 (69–72)
1989–1993	6 390	67 (65–68)	2 738	71 (69–74)	166	80 (71–89)	3 408	69 (67–71)	7 564	72 (71–74)
1994–1998	6 476	68 (67–70)	3 096	72 (70–75)	199	74 (66–83)	4 129	73 (71–74)	7 683	73 (72–74)
1999–2003	6 534	71 (69–72)	3 050	74 (73–76)	213	76 (70–82)	4 158	73 (72–75)	8 169	74 (73–75)
Women
1964–1968	983	44 (41–48)	299	35 (30–42)	23	59 (46–76)	465	32 (27–37)	1 438	52 (49–56)
1969–1973	1 306	47 (44–51)	415	45 (40–51)	36	59 (46–76)	791	47 (43–51)	1 814	59 (57–62)
1974–1978	1 682	48 (46–51)	585	53 (49–58)	37	58 (46–72)	951	54 (50–58)	1 960	62 (59–65)
1979–1983	1 908	55 (52–57)	658	63 (58–67)	47	58 (46–72)	995	53 (49–57)	2 176	64 (62–67)
1984–1988	2 186	57 (54–59)	765	62 (58–66)	68	80 (69–93)	1 015	55 (51–59)	2 521	65 (63–67)
1989–1993	2 368	62 (60–64)	1 008	62 (58–65)	45	62 (52–73)	1 153	59 (56–63)	2 673	69 (67–71)
1994–1998	2 338	62 (60–65)	1 058	72 (69–75)	78	62 (52–73)	1 438	67 (64–70)	2 840	69 (67–71)
1999–2003	2 417	62 (60–64)	1 058	72 (69–75)	81	71 (62–81)	1 565	68 (66–70)	3 098	68 (67–70)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

Figure 4. Trends in age-standardised (ICSS) excess death rates per 100 person years for bladder cancer by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003.

Table IV. Trends in 5-year age-specific relative survival in percent after bladder cancer by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	67	61	49	39	29	24	50	53	45	44	30	0
1969–1973	77	63	55	42	24	0	67	55	46	41	37	26
1974–1978	78	70	58	46	36	26	62	60	49	46	25	0
1979–1983	86	72	63	54	40	35	70	63	57	47	43	13
1984–1988	87	72	65	56	46	7	82	66	63	47	33	15
1989–1993	88	79	70	59	47	46	85	72	61	56	44	48
1994–1998	88	79	68	62	52	33	85	77	66	56	33	19
1999–2003	87	79	72	66	54	43	84	75	66	53	38	26
Finland
1964–1968	64	48	39	33	7	*	73	53	39	22	5	*
1969–1973	65	67	48	35	24	*	83	56	46	33	24	*
1974–1978	75	68	55	50	34	0	78	64	58	40	37	*
1979–1983	83	74	66	55	51	72	80	77	62	59	40	73
1984–1988	87	77	68	59	59	73	80	72	68	54	41	0
1989–1993	89	80	70	70	52	63	84	77	66	53	37	12
1994–1998	89	83	73	67	57	46	88	88	77	63	49	49
1999–2003	89	83	75	70	61	44	88	82	77	63	58	41
Iceland
1964–1968	58	62	64	41	55	*	71	71	68	50	37	*
1969–1973	58	62	64	41	55	*	71	71	68	50	37	*
1974–1978	102	78	66	70	36	*	65	65	62	56	40	*
1979–1983	102	88	64	63	62	*	65	65	62	56	40	*
1984–1988	102	93	74	55	52	*	75	75	94	36	152	*
1989–1993	96	90	69	84	64	*	63	63	74	63	33	*
1994–1998	79	84	68	82	52	82	63	63	74	63	33	*
1999–2003	93	87	78	62	71	61	87	87	77	66	40	*
Norway
1964–1968	44	45	38	29	22	0	56	40	31	25	15	0
1969–1973	80	64	54	48	44	0	60	65	49	39	26	25
1974–1978	83	73	64	57	46	23	67	63	60	46	36	29
1979–1983	88	68	62	54	37	58	71	71	51	47	31	0
1984–1988	83	76	66	55	50	78	69	63	64	44	41	34
1989–1993	85	80	71	62	51	64	71	70	64	51	46	19
1994–1998	89	81	74	65	60	29	85	76	69	63	45	30
1999–2003	90	82	75	69	56	42	86	75	73	61	50	20
Sweden
1964–1968	79	68	55	43	26	0	66	62	53	50	35	16
1969–1973	82	70	62	50	34	0	90	72	63	51	31	19
1974–1978	84	78	67	57	49	57	79	70	64	54	51	53
1979–1983	89	77	72	58	54	54	87	69	67	61	44	26
1984–1988	90	80	73	64	54	33	89	76	69	58	41	27
1989–1993	88	80	75	67	58	43	87	82	68	63	53	35
1994–1998	87	83	76	68	54	56	84	77	80	61	46	46
1999–2003	88	83	76	69	58	43	77	80	76	60	49	42

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival

*Too few patients to calculate survival, see ref. [9].

Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 and followed up to the end of 2006. Material and methods. Acta Oncol.

 Google Scholar